- Merck, a leading science and technology company, today announced the launch of its new consumer brand ...
- LEO Pharma A/S, a global pharmaceutical company specialising in dermatology, has entered into ...
-11 Inaugural winners receive US$3 million each for Groundbreaking Achievements in Life Science ...
Grade Recommendation: Strong (Highest) GREENWICH, Connecticut, Feb. 11, 2013 ...
- BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices and an emerging ...
- Berg Pharma, a Boston based pharmaceutical company presented novel data today pertaining to ...
- Ingenuity(R) iReport(TM) for Real-Time PCR, optimized for TaqMan(R)Gene Expression Assays ...
- - Findings from Two-Year Pivotal Phase III TEMSO Trial ...
- - First Randomized Controlled Trial to Show That Basal Plus ...
Gadjah Mada University (UGM) will hold a national seminar on the benefits, safety and development prospects of ...
- - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...
- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...
- Results of a new analysis from the largest-ever morbi-mortality study of ...
Indonesia has called on the international community to cut global demand for narcotics and drugs as part of a ...
-Evaluation of Alternative Treatment Strategies Incorporating Platelet Function Testing Recommended ...